2003
DOI: 10.1039/b310198c
|View full text |Cite
|
Sign up to set email alerts
|

Photochemical and thermal synthesis and characterization of polypyridine ruthenium(ii) complexes containing different monodentate ligandsElectronic supplementary information (ESI) available: View of the dimeric units of 8 and proton indexation used in the 1H NMR data. See http://www.rsc.org/suppdata/dt/b3/b310198c/

Abstract: The photochemical and thermal synthesis of a series of [Ru(tpy)(phen)L] 2ϩ complexes where terpy = 2,2Ј:6Ј,2Љterpyridine (terpy) or 4-(3,5-di-tert-butyl)phenyl-2,2Ј;6Ј,2Љ-terpyridine (terpy*), phen = 1,10-phenanthroline and L monodentate ligands such as Cl Ϫ , NC Ϫ , CH 3 CN, pyridine, isoquinoline (iq), 4-dimethylaminopyridine (dmap), 4-(4Ј-methylpyridinium)pyridine (mqt), phenothiazine (ptz), 3,5-lutidine(lut) and H 2 O are described. The complexes have been characterized by 1 H (COSY and ROESY) NMR spectros… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
49
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 66 publications
(54 citation statements)
references
References 33 publications
5
49
0
Order By: Relevance
“…The bond lengths and angles are within the range found for similar structures described in the literature. [48][49][50][51][55][56][57][58][59][60][61][62][63] In structures 13 and 14, the shortest Ru-N bond length is the Ru-N bond to the central pyridine ring in ttp ligand. The Ru-N bond distances in bpy ligands which are trans to the monodentate ligands (Cl or bpe) are shorter than those in the other pyridine rings in bpy ligands.…”
Section: Resultsmentioning
confidence: 99%
“…The bond lengths and angles are within the range found for similar structures described in the literature. [48][49][50][51][55][56][57][58][59][60][61][62][63] In structures 13 and 14, the shortest Ru-N bond length is the Ru-N bond to the central pyridine ring in ttp ligand. The Ru-N bond distances in bpy ligands which are trans to the monodentate ligands (Cl or bpe) are shorter than those in the other pyridine rings in bpy ligands.…”
Section: Resultsmentioning
confidence: 99%
“…The syntheses of complexes of the type Ru(terpy)(phen)(L) 2+ have been described for a great variety of ligands L (chloride, water, acetonitrile, benzonitrile derivatives, pyridines substituted in 3,4 and/or 5 positions, sulfoxides, and thioethers). [22,23] The absorption maxima of these complexes vary with the nature of the monodentate ligands, from ca. 430 nm for sulfoxides to ca.…”
Section: +mentioning
confidence: 99%
“…12). [22] In Ru(terpy)(phen)(L) 2+ complexes, the monodentate nature of the leaving ligand L and the less-crowded coordination sphere around the ruthenium center compared to Ru(diimine) 3…”
Section: Ru(diimine) 3 2+ Corementioning
confidence: 99%
“…Meanwhile, the UV/Vis spectra of [3] 2 + and [4] 2 + in water show metal-toligand charge transfer (MLCT) bands in the visible region characterized by absorption maxima at 452 and 444 nm, respectively (see the Supporting Information, Figure S5), which is consistent with thioether-bound ruthenium complexes. [29] Finally, both compounds show only one darkorange spot, observed by TLC on silica gel. Thus, the presence of the two close A6 doublets for complex [3] 2 + can be explained by considering the chirality of N-acetyl-l-methionine.…”
mentioning
confidence: 97%
“…[24,25] Secondly, unlike nitrogen-based ligands, thioethers are only weakly basic in water, which might make their ruthenium complexes less sensitive to pH changes. Finally, visible-light irradiation leads to the controlled release of thioether ligands, [26][27][28][29] which feature might be used to deliver locally the cytotoxic form of the ruthenium complex at the desired location ( Figure 1, route 2). The use of light to cure cancer, which has notably led to the clinical development of photodynamic therapy, [30][31][32] has also been proposed as an interesting development in metal-based anticancer drug research, in which the presence of oxygen is not required.…”
mentioning
confidence: 99%